Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:33 PM
Ignite Modification Date:
2025-12-24 @ 3:33 PM
NCT ID:
NCT02044692
Eligibility Criteria:
Inclusion Criteria:
* Patients who have a diagnosis of Hunter syndrome(Mucopolysaccharidosis II).
* Patients who are administered idurasulfase-beta or willing to be administered idurasulfase-beta.
* Patient's parent(s), or patient's legal guardian must have given voluntary written consent to participate in the study.
Exclusion Criteria:
* Patients who have participated in any other blind clinical trials.
* Patient who cannot be tracked about safety.
* Patients who are judged disqualified to participate clinical trials by investigator for other causes.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02044692
Study Brief:
Protocol Section:
NCT02044692